Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Abbvie Inc Drug Patent Portfolio

Abbvie Inc's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Abbvie Inc News

AbbVie Fails in Patent Attempt for Cancer Medication Venetoclax in India, Opening Doors for Generic Versions

23 Jan, 2026

Patent denial for multinational corporation's cancer medication; generics expected to launch in the market - The Economic Times

23 Jan, 2026

Indian Patent Office denies AbbVie's patent application for the cancer medication Venetoclax, paving the way for generic versions to potentially enter the market.

23 Jan, 2026

Patent denial for multinational corporation's cancer medication, generics expected to emerge | India News - The Times of India

22 Jan, 2026

See More